Status:
COMPLETED
Ramosetron Pre-treatment for PONV and QT Prolongation
Lead Sponsor:
Konkuk University Medical Center
Conditions:
PONV
Prolonged QTc Interval
Eligibility:
FEMALE
19-99 years
Phase:
PHASE4
Brief Summary
Ramosetron is commonly used to prevent postoperative nausea and vomiting (PONV) in the Eastern Asia. The prolongation of QTc interval is a main side effect. In this study, the pre-treatment time of ra...
Detailed Description
This prospective study evaluate 42 female patients who underwent laparoscopic gynecologic surgery under general anesthesia. Group I (n=21) receive 0.6mg of ramosetron at anesthesia induction. Group R ...
Eligibility Criteria
Inclusion
- patients who underwent laparoscopic gynecologic surgery
Exclusion
- preoperative bradyarrhythmia in ECG
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03278522
Start Date
July 1 2017
End Date
February 28 2018
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lee Sung Ho
Seoul, South Korea, 05030